Almirall, S.A.
BME:ALM 株式レポート
Almirall 過去の業績
Almirallの収益は年間平均-62.1%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間13.1% 1%割合で 増加しています。
主要情報
Pharmaceuticals 業界の成長 | 5.0% |
収益成長率 | 1.0% |
株主資本利益率 | -2.4% |
ネット・マージン | -3.8% |
前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Almirall (BME:ALM) Has A Somewhat Strained Balance Sheet
Nov 06Investors Continue Waiting On Sidelines For Almirall, S.A. (BME:ALM)
Sep 07Almirall, S.A.'s (BME:ALM) Intrinsic Value Is Potentially 90% Above Its Share Price
Jul 12Market Participants Recognise Almirall, S.A.'s (BME:ALM) Revenues
Apr 24These 4 Measures Indicate That Almirall (BME:ALM) Is Using Debt Reasonably Well
Mar 20Here's Why Almirall (BME:ALM) Can Manage Its Debt Responsibly
Dec 15Is There An Opportunity With Almirall, S.A.'s (BME:ALM) 21% Undervaluation?
Oct 03We Think Almirall (BME:ALM) Can Stay On Top Of Its Debt
Aug 24Is There An Opportunity With Almirall, S.A.'s (BME:ALM) 31% Undervaluation?
Jul 05Is Almirall (BME:ALM) A Risky Investment?
May 16Estimating The Fair Value Of Almirall, S.A. (BME:ALM)
Mar 29We Think Almirall (BME:ALM) Can Stay On Top Of Its Debt
Jan 04An Intrinsic Calculation For Almirall, S.A. (BME:ALM) Suggests It's 29% Undervalued
Dec 01Almirall (BME:ALM) Seems To Use Debt Quite Sensibly
Jul 14Here's Why Almirall (BME:ALM) Can Manage Its Debt Responsibly
Mar 23Almirall, S.A.'s (BME:ALM) Intrinsic Value Is Potentially 82% Above Its Share Price
Feb 24Is Almirall (BME:ALM) Using Too Much Debt?
Nov 01Almirall, S.A.'s (BME:ALM) Intrinsic Value Is Potentially 77% Above Its Share Price
Aug 02Is Almirall (BME:ALM) Using Too Much Debt?
Jul 06Here's Why Almirall (BME:ALM) Has A Meaningful Debt Burden
Mar 23How Does Almirall, S.A. (BME:ALM) Fare As A Dividend Stock?
Mar 05Almirall, S.A. (BME:ALM) Shares Could Be 41% Below Their Intrinsic Value Estimate
Feb 15Almirall の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
BME:ALM 収益、費用、利益 ( )EUR Millions日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|
30 Jun 24 | 932 | -35 | 220 | 0 |
31 Mar 24 | 915 | -39 | 214 | 3 |
31 Dec 23 | 899 | -38 | 209 | 0 |
30 Sep 23 | 907 | 7 | 209 | 7 |
30 Jun 23 | 898 | -11 | 201 | 0 |
31 Mar 23 | 882 | -8 | 205 | 3 |
31 Dec 22 | 879 | 4 | 202 | 0 |
30 Sep 22 | 864 | 9 | 207 | 24 |
30 Jun 22 | 856 | 29 | 197 | 0 |
31 Mar 22 | 843 | -50 | 190 | 8 |
31 Dec 21 | 837 | -41 | 188 | 0 |
30 Sep 21 | 814 | -22 | 201 | -10 |
30 Jun 21 | 809 | -11 | 185 | 0 |
31 Mar 21 | 790 | 55 | 188 | -8 |
31 Dec 20 | 814 | 74 | 177 | 0 |
30 Sep 20 | 849 | 63 | 167 | -8 |
30 Jun 20 | 872 | 86 | 188 | 0 |
31 Mar 20 | 926 | 121 | 188 | 0 |
31 Dec 19 | 911 | 106 | 189 | 0 |
30 Sep 19 | 858 | 85 | 227 | 9 |
30 Jun 19 | 884 | 88 | 182 | 0 |
31 Mar 19 | 789 | 80 | 209 | 3 |
31 Dec 18 | 811 | 78 | 183 | 0 |
30 Sep 18 | 714 | -111 | 176 | -10 |
30 Jun 18 | 730 | -179 | 196 | 0 |
31 Mar 18 | 687 | -293 | 195 | -6 |
31 Dec 17 | 677 | -304 | 207 | 0 |
30 Sep 17 | 735 | -128 | 215 | 5 |
30 Jun 17 | 755 | -78 | 214 | 0 |
31 Mar 17 | 821 | 73 | 216 | 5 |
31 Dec 16 | 822 | 75 | 213 | 0 |
30 Sep 16 | 778 | 162 | 230 | 10 |
30 Jun 16 | 743 | 154 | 210 | 0 |
31 Mar 16 | 721 | 111 | 204 | 2 |
31 Dec 15 | 738 | 132 | 201 | 0 |
30 Sep 15 | 783 | 479 | 190 | -28 |
30 Jun 15 | 802 | 488 | 244 | 0 |
31 Mar 15 | 842 | 481 | 250 | -11 |
31 Dec 14 | 828 | 448 | 274 | 0 |
30 Sep 14 | 868 | -13 | 262 | -11 |
30 Jun 14 | 849 | -32 | 256 | 0 |
31 Mar 14 | 845 | -33 | 261 | 0 |
31 Dec 13 | 825 | -34 | 250 | 0 |
過去の収益成長分析
収益動向: ALMは利益が出ておらず、過去 5 年間で損失は年間62.1%の割合で増加しています。
成長の加速: ALMの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: ALMは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 8.8% ) と比較することは困難です。
株主資本利益率
高いROE: ALMは現在利益が出ていないため、自己資本利益率 ( -2.36% ) はマイナスです。
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}